Stay updated on Empagliflozin in Heart Failure Clinical Trial
Sign up to get notified when there's something new on the Empagliflozin in Heart Failure Clinical Trial page.

Latest updates to the Empagliflozin in Heart Failure Clinical Trial page
- CheckyesterdayChange DetectedRevision tag updated from v3.5.3 to v3.5.4, indicating a minor update to the page’s metadata and not altering the study details or content. No data or content changes are evident.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe ClinicalTrials.gov page footer version was updated from v3.5.2 to v3.5.3, reflecting a site release rather than a modification to the study information shown.SummaryDifference0.1%

- Check29 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page now shows a new system revision label 'Revision: v3.5.0' and the previous 'Revision: v3.4.3' entry has been removed.SummaryDifference0.1%

- Check72 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check94 days agoChange DetectedA new site revision, v3.4.2, was added and the previous revision v3.4.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Empagliflozin in Heart Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Empagliflozin in Heart Failure Clinical Trial page.